Alembic Pharma gets USFDA approval for generic chronic constipation treatment tablets
Cite this
Citations are auto-generated; verify before publishing. The analysis classification is PolicyDhara's, not the source's.
Policy framework or directive — a strategic document setting direction, principles, and objectives for governance. Guides the design of schemes, legislation, and implementation strategies.
Summary
Alembic Pharmaceuticals has received USFDA approval for its generic prucalopride tablets used to treat chronic idiopathic constipation in adults, enabling the company to address a market estimated at US$ 100 million in the United States.